The Life Sciences sector includes companies involved in biopharmaceuticals, medical manufacturing and distribution, and bio products.
nDatalyze Corp. generates technology-based, health-related solutions. Investors are encouraged to contact the Corporation by email at jimd@ndatalyze.com or by telephone at (403) 689-3901.
NetraMark Holdings is an AI healthtech company focused on addressing both acute and non-acute brain-centric conditions. We have developed an ecosystem of innovative products that directly support brain-related conditions. Our world-renowned team and partners are disrupting traditional mental wellness treatments and are positioned at the forefront of critical research and innovations. NetraMark, a wholly owned subsidiary of NetraMark Holdings Inc., is providing proprietary next-generation AI solutions for pharmaceutical and biotechnology companies across the spectrum of disease. The company is based in Toronto, Ontario. For more information, visit https://www.netramark.com/ .
Nevis innovates and develops cannabis products that have been consumed by millions of consumers across multiple markets in the United States. Led by our flagship brand Major(TM) Nevis partners with leading cannabis product manufacturers and distributors to enhance their product offerings.
The Issuer will provide consulting services, real property, intellectual property, equipment for lease and enhanced ancillary services to a licensed cannabis processor.
Nextleaf® is a federally regulated manufacturer and distributor of cannabis vapes and oils under its award-winning prohibition-era brand, Glacial Gold™. The Vancouver-based company sells its branded products through government distributors and authorized retailers in 5 provinces in Canada. Nextleaf is a low-cost producer of cannabis oils, and supplier of THC and CBD ingredients to qualified wholesale partners across Canada and internationally. Nextleaf’s patented ingredient processing technology transforms cannabis and hemp biomass into high-purity distillate at an industrial scale. The Company has been issued 19 U.S. patents, and 100 patents globally, on cannabinoid processing including extraction, distillation, and acetylation.
For more information visit www.nextleafsolutions.com and www.Glacial.Gold
Nirvana Life Sciences Inc. is focused on developing medical products and regimens that address addiction. Nirvana is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency and other health problems.
Nova Net Lease REIT was formed to acquire specialized industrial and retail properties leased to experienced, top-tier, creditworthy, state-licensed operators in the legal U.S. cannabis industry
Onco-Innovations Limited is a Canadian biotech company dedicated to developing and commercializing treatments for various types of cancer. The company holds an exclusive license for the PNKP Inhibitor Technology and an exclusive sublicense for the Drug Delivery Technology. Together, these technologies have shown the potential to significantly enhance treatment outcomes, particularly for colorectal cancer.
Optimi Health is the only psychedelics pharmaceutical manufacturer in Canada with both a Controlled
Drugs and Substances Dealer’s Licence and a Drug Establishment Licence (DEL). Specializing in controlled
substances such as botanical psilocybin and MDMA, Optimi is dedicated to supplying safe, top-tier GMPgrade
products and API to researchers, drug developers, and authorized patients in markets across the
world.
Our leadership is reinforced by our state-of-the-art, GMP-compliant cultivation, formulation, and
analytical facilities, purpose-built to develop proprietary formulations that meet the highest standards of
quality and responsible sourcing. Located in Princeton, British Columbia, our two facilities total 20,000
square feet where all products are grown and manufactured in-house under strict GACP and GMP
conditions, ensuring unparalleled quality and reliability. Optimi Health is committed to being the most
trusted and compassionate supplier of safe drug candidates worldwide.
Optimind Pharma Corp. specializes in prescribing medical cannabis and other alternative treatments for various medical ailments. The Issuer prides itself on providing quality education and health care to patients. The Issuer is also an emerging provider of psychedelic therapies at its clinic, helping people suffering from PTSD, anxiety, depression, and other mental illnesses and disabilities by providing ketamine assisted treatment and other psychedelic enhanced psychotherapy modalities.
